This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
This piece analyzes whether retirement funds should favor index or target date options, emphasizing long-term planning and goal alignment.
26,209 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Privacy-focused crypto Zcash is quietly advancing features that could challenge Bitcoin and Ethereum. This in-depth g...
The levered BOIL ETF aims for double daily moves in natural gas, but ongoing contango and roll costs erode value for ...
South Korea's possible investment in NuScale Power's SMR program could shift the nuclear landscape and offer new oppo...
Craving a position in SpaceX before it goes public? An ETF that blends public and late-stage private exposure, like X...
The U.S. Treasury must refinance about $8 trillion in debt over the next year, a record load that market watchers say...
Rivian priced a 75 million share secondary offering, sending its stock down around 14% and triggering a market-wide p...
As Tesla fans cheer long-term robotaxi dreams, traders worry about delivery misses. A growing crowd is exploring inve...
Archer Aviation sits at a pivotal crossroads as FAA progress updates loom and defense contracts lurk in the wings. Th...
As remote work grows, understanding tax deductions for home office 2026 can save you money. This guide breaks down el...
Mortgage-report fees are climbing again as Experian and other bureaus raise pricing. Industry sources say the latest ...
Baidu shares slumped after a hefty impairment charge underscored the heavy costs of its AI push, even as AI Cloud rev...